In recent years, there has been rapid growth in understanding the genetic basis for a wide variety of cardiovascular disorders. Brigham and Women’s Heart and Vascular Genetics Program is on the forefront of research into the molecular basis for genetic cardiac disease and is applying that knowledge to the clinical setting, enhancing the care of patients and their families.
The Heart and Vascular Genetics Program at Brigham and Women’s Hospital is composed of a multidisciplinary team of nationally recognized physicians and scientists who work together to take the latest discoveries in research on inherited cardiac disease and apply them directly to the patient.
Research for the Heart and Vascular Genetics Program focuses on the origins of hypertrophic cardiomyopathy (HCM) and the molecular basis of inherited cardiac disorders.
Christine E. Seidman, MD, Director of the Cardiovascular Genetics Center at Brigham and Women’s Hospital, describes how genetic changes can lead to an increased risk of heart disease in families. Read the Genes and Heart Failure video transcript.
We offer comprehensive evaluation, diagnosis and management of those who are at risk for or have an inherited cardiac disorder. We specialize in managing the following conditions:
- Hypertrophic cardiomyopathy
- Marfan syndrome/connective tissue disorders
- Dilated cardiomyopathy
- Arrhythmogenic right ventricular dysplasia
- Long QT syndrome and other inherited arrhythmias including including Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia
- Familial sudden cardiac death
- Inherited aortic aneurysms
- Premature coronary artery disease/myocardial infarction
- Familial atrial fibrillation
The Heart and Vascular Genetics Program, located in our state-of-the-art Shapiro Cardiovascular Center, pulls together the latest research and technologies to offer comprehensive leading-edge evaluation, diagnosis, and management to individuals at risk for inherited cardiac disease.
This page was last modified on 9/23/2016